Prevalence of Abnormal Thrombophilia Profile in Chronic Kidney Disease

Authors

  • Sehrish Khurshid Assistant Professor, Department of Pathology, Hamdard University, Pakistan
  • Rabbia Tariq Department of Pathology, Isra University
  • Javeria Qureshi Department of Hematology, Sindh Institute of Urology and Transplantation
  • Raffia Mazher Department of Nephrologhy, Liaquat University of Medical and Health Sciences

Keywords:

Activated Protein C resistance, Anti thrombin-III, Chronic Kidney Disease, Lupus anticoagulant, Protein C, Protein S, Thrombophilia

Abstract

Objective: To determine the prevalence of altered thrombophilia in chronic kidney disease.

Study Design: Descriptive retrospective study

Place and duration of study: The study was conducted at Isra University hospital from June 2019 to December 2020

Material and Methods: 150 patients of stage 3, 4 and 5 of chronic kidney disease were enrolled in the study. Patients with stage 1 and 2 chronic kidney disease and on anticoagulation treatment were excluded from study. Stages of chronic kidney disease were classified according to KDIGO criteria. Thrombophilia screening for Antithrombin-III, protein C, protein S, Lupus anticoagulant and Activated Protein C was performed on coagulation analyzer. Findings were recorded and data were analyzed by SPSS version 25

Results: Fifty Seven out of 150 patients were positive for thrombophilia screening with Antithrombin-III deficiency in 28.3%, Protein C deficiency in 7.9%, Protein S deficiency in 3.3%, Lupus anticoagulant in 6.6% and activated Protein C resistance in 2.0%. Out of 43 Antithrombin-III deficient patients, 53.4% (n=23) were on hemodialysis. Out of 12 Protein C deficient patients, 58.3 %(n=7) were on hemodialysis. Out of 10 patients with lupus anticoagulant, 60% (n=6) were on hemodialysis and out of 3 patients with Activated Protein C resistance, 33.3% (n=1) were on hemodialysis.

Conclusion: In this study, Antithrombin-III deficiency was most common finding in CKD and thrombophilia was most common in stage 5 chronic kidney disease and lupus anticoagulant was common finding in relation to hemodialysis.  More studies are needed to define true significance of thrombophilia screening in all stages of CKD patients.

Downloads

Published

2021-08-23

Issue

Volume.19, Issue-1 (Jan-Mar 2021)

Section

Original article

License

Copyright (c) 2021 Sehrish Khurshid; Rabbia Tariq, Javeria Qureshi, Raffia Mazher

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purpose. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

How to Cite

1.
Khurshid S. Prevalence of Abnormal Thrombophilia Profile in Chronic Kidney Disease. Int J Pathol [Internet]. 2021 Aug. 23 [cited 2024 Nov. 23];19(1):2-5. Available from: https://jpathology.com/index.php/OJS/article/view/630